These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6913222)

  • 1. [Drug information: antiparkinson agents. I. Anticholinergic agents].
    Veje VO
    Sygeplejersken; 1981 Sep; 81(34):11. PubMed ID: 6913222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticholinergic antiparkinson agents].
    Taurand P
    Soins Psychiatr; 1988 Nov; (97):I-II. PubMed ID: 3242060
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of anticholinergic medication to symptom change in schizophrenia.
    DeQuardo JR; Kloss RJ
    J Clin Psychiatry; 1993 Sep; 54(9):356-7. PubMed ID: 8407855
    [No Abstract]   [Full Text] [Related]  

  • 4. [The search for anticholinergic drugs. XLIV. Synthesis of derivatives of 1-adamantane-carboxylic acid].
    Cessak M; Lempke T; Woliński J
    Acta Pol Pharm; 1985; 42(5):429-32. PubMed ID: 3834762
    [No Abstract]   [Full Text] [Related]  

  • 5. [ANTIPARKINSON DRUGS].
    CERRI O; VALCURONE G
    Boll Chim Farm; 1965 Jan; 104():7-22. PubMed ID: 14300054
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of anticholinergic antiparkinson agents against adverse drug reactions in a psychiatric department. A quality assurance project].
    Mikkelsen VR
    Ugeskr Laeger; 1998 Jul; 160(29):4323-5. PubMed ID: 9679438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticholinergic anti-Parkinson agents].
    Taurand S
    Soins; 1996 Apr; (605):61-2. PubMed ID: 8716255
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug information: antiparkinson agents. II. Dopaminergic agents].
    Veje JO
    Sygeplejersken; 1981 Sep; 81(36):9, 26. PubMed ID: 6913237
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influencing of the subnarcotic and cholinergically potentiated action of barbital through antiparkinson drugs in mice].
    Oelszner W; Westermann KH; Eger J
    Acta Biol Med Ger; 1971; 27(5):993-9. PubMed ID: 5148782
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of the activating system including its use for screening antiParkinson drugs.
    HIMWICH HE; RINALDI F
    Yale J Biol Med; 1955 Dec-1956 Feb; 28(3-4):308-19. PubMed ID: 13291855
    [No Abstract]   [Full Text] [Related]  

  • 11. Abuse of the antiparkinson drugs: a review of the literature.
    Smith JM
    J Clin Psychiatry; 1980 Oct; 41(10):351-4. PubMed ID: 7430078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug information: antiparkinson agents III. Amantadine (Symmetrel), bromocriptine (Parlodel)].
    Veje JO
    Sygeplejersken; 1981 Sep; 81(38):20. PubMed ID: 6914040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical pharmacology of anticholinergic antiparkinson agents. A review with emphasis on acute toxicity].
    Gjerden P; Slørdal L
    Tidsskr Nor Laegeforen; 1998 Jan; 118(1):53-5. PubMed ID: 9481912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ; Chouinard G
    Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
    [No Abstract]   [Full Text] [Related]  

  • 15. [Misuse of anticholinergic agents with central effects].
    Alvăn G; Nordin C; Rydberg U
    Lakartidningen; 1982 Oct; 79(42):3834-5. PubMed ID: 7154760
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacodynamics of antiparkinsonian substances].
    FROMMEL E; GAILLAND LA; FLEURY C
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():97-109. PubMed ID: 13825372
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiparkinsonian drugs (author's transl)].
    Ando K
    No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed extinction of executive sets associated with decreased cholinergic function: a mechanism of perseverative and intrusive behavior.
    Galdi JA
    Brain Cogn; 1993 May; 22(1):1-18. PubMed ID: 8098943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
    Jackisch R; Huang HY; Reimann W; Limberger N
    J Pharmacol Exp Ther; 1993 Feb; 264(2):889-98. PubMed ID: 8094757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effectiveness of the use of new types of antiparkinson agents].
    Federmann J; Honzáková L; Roth B; Stika L
    Cesk Zdrav; 1981 Jun; 29(6):229-41. PubMed ID: 7261170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.